A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

NCT01908829 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)

NCT01533597 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients

NCT01745094 ·Status: COMPLETED ·Phase: PHASE4

SVT-40776 in Patients Suffering From Overactive Bladder Syndrome

NCT00507169 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.

NCT00269750 ·Status: COMPLETED ·Phase: PHASE3

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)

NCT01314872 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)

NCT03594058 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder

NCT05282069 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects

NCT02938507 ·Status: COMPLETED ·Phase: PHASE1

Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder

NCT06024005 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

NCT01638000 ·Status: COMPLETED ·Phase: PHASE3

Therapy of the Overactive Bladder Syndrome

NCT01314781 ·Status: COMPLETED ·Phase: PHASE4

Solifenacin Succinate Versus Tolterodine 4mg Once Daily

NCT00802373 ·Status: COMPLETED ·Phase: PHASE3

Reproducibility Study of OABSS and Its Response to Treatment

NCT02667470 ·Status: COMPLETED ·Phase: PHASE4

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00688688 ·Status: COMPLETED ·Phase: PHASE3

Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder

NCT02129816 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.

NCT00338624 ·Status: COMPLETED ·Phase: PHASE3

Study of ONO-8577 in Patients With Overactive Bladder

NCT03106623 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis

NCT00629642 ·Status: COMPLETED ·Phase: PHASE4

Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

NCT00773552 ·Status: WITHDRAWN ·Phase: PHASE4

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

NCT00212706 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence

NCT01157377 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

NCT00350636 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00912964 ·Status: COMPLETED ·Phase: PHASE3